Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

Merck Licenses Coley Pharma's VaxImmune for $4 Million

Filed in archive Corporate and Industrial News by ruth on April 13, 2007

Merck Licenses Coley Pharma's VaxImmune for $4 Million
Merck & Co., Inc. has licensed Coley Pharmaceutical's VaxImmune(TM) vaccine adjuvant for an upfront license fee of $4 million, and milestone fess of up to $33 million plus royalties.
VaxImmune is a proprietary Toll-like receptor 9 (TLR9) agonist designed to induce both an enhanced antigen-specific antibody response and a natural killer T-cell immune response when used in combination with prophylactic (preventative) or therapeutic vaccines.
VaxImmune is currently under clinical trials for various cancer, infectious diseaselinks and biowarfare applications.

Source: Coley Pharmaceutical
Photo: TLR Therapeutics, Coley Pharmaceuticals


Advertisement


Permalink: Merck Licenses Coley Pharma's VaxImmune for $4 Million
Tags: merck  license  investment  pharma  vaximmune  vaccine  biotech  coley  vaximmune+million 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/63383



Advertisement


Advertisement


RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter

Use our search feature to look for other interesting posts

Just this blog Whole network
 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give Luis a call at +1 (650) 331 8047.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network







 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells